Literature DB >> 30902744

Shenmai injection maintains blood-brain barrier integrity following focal cerebral ischemia via modulating the expression and trafficking of occludin in lipid rafts.

Huaming Xu1, Yuan Liu2, Dongsheng Wang3, Zhenqiang Zhang4.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Shenmai injection (SMI), a traditional Chinese herbal medicine is widely used for the clinical treatment of cerebral infarction in China. AIM OF THE STUDY: Tight junctions (TJs) are major components of the blood-brain barrier (BBB) that physically restrict the paracellular diffusion of blood-borne substances between endothelial cells into the CNS. TJ proteins are associated with cholesterol-enriched regions of plasma membrane known as lipid rafts, which are critical for the trafficking, positioning and function of TJ proteins. In this study, we investigated the effect of SMI on the expression and trafficking of the key TJ-associated protein, occludin, in lipid rafts.
MATERIALS AND METHODS: Using a neutral pH, rat cerebral microvessels were subjected to detergent-free density-gradient fractionation to isolate lipid rafts containing occludin. Transmission electron microscopy (TEM) was performed to study the effects of drug administration on ultrastructural changes to TJs. Western blotting (WB), immunofluorescence (IF), and co-immunoprecipitation (COIP) were used to observe the localization and function of TJ-associated proteins.
RESULTS: We successfully isolated cerebral microvessels and separated lipid rafts from plasma membranes. With SMI treatment, extravasation of FITC-albumin decreased around the cerebral vessels by IF, the tight junctions were found to still be intact and the basement membrane appeared to be of uniform thickness in TEM. Compared with the untreated group, the co-expression of flotillin-1 and occludin in microvascular endothelial cells was increased and distributed continuously in SMI treatment as shown in double label IF. SMI significantly increased the translocation of occludin to lipid raft fractions by WB and COIP.
CONCLUSIONS: SMI helps maintain the proper assembly of the TJ multiprotein complex in lipid rafts, thereby helping to preserve BBB functional integrity during focal cerebral ischemic insult. Our findings enhance our understanding of the mechanisms underlying the neuroprotective effect of SMI in cerebral ischemia.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Blood–brain barrier; Ischemia; Lipid rafts; Occludin; Tight junctions

Mesh:

Substances:

Year:  2019        PMID: 30902744     DOI: 10.1016/j.jep.2019.03.034

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  6 in total

1.  The Neuroprotective Effect of Shenmai Injection on Oxidative Stress Injury in PC12 Cells Based on Network Pharmacology.

Authors:  Jing Wu; Jiang Wu; Zhonghao Li; Xiaoke Dong; Siyuan Yuan; Jinmin Liu; Le Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-05-27       Impact factor: 2.650

2.  Screening for Interacting Proteins with Peptide Biomarker of Blood-Brain Barrier Alteration under Inflammatory Conditions.

Authors:  Karina Vargas-Sanchez; Monica Losada-Barragán; Maria Mogilevskaya; Susana Novoa-Herrán; Yehidi Medina; Cristian Buendía-Atencio; Vaneza Lorett-Velásquez; Jessica Martínez-Bernal; Rodrigo E Gonzalez-Reyes; David Ramírez; Klaus G Petry
Journal:  Int J Mol Sci       Date:  2021-04-29       Impact factor: 5.923

3.  Shenmai injection enhances cisplatin-induced apoptosis through regulation of Mfn2-dependent mitochondrial dynamics in lung adenocarcinoma A549/DDP cells.

Authors:  Yushi Chen; Ye Sun; Qiuyu Zhao; Chunying Liu; Chun Wang
Journal:  Cancer Drug Resist       Date:  2021-12-10

Review 4.  Herbal Medicine, Gut Microbiota, and COVID-19.

Authors:  Ziqi Chen; Yiwen Lv; Huachong Xu; Li Deng
Journal:  Front Pharmacol       Date:  2021-07-07       Impact factor: 5.988

5.  Efficacy and Safety of a Combination of Shenmai Injection plus Chemotherapy for the Treatment of Lung Cancer: A Meta-Analysis.

Authors:  Guo-Wei Qin; Tong-Tong Xu; Xiang-Wei Lv; Shi-Min Jiang; Ke-Jia Zhang; Ming Xu; Lu Fu; Qi Wu; Yao Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2021-04-13       Impact factor: 2.629

6.  Effects of Shenmai injection combined with platinum-containing first-line chemotherapy on quality of life, immune function and prognosis of patients with nonsmall cell lung cancer: A protocol for systematic review and meta-analysis.

Authors:  Yanqiong Chen; Chao Zhang; Cheng Pan; Yunkui Yang; Jin Liu; Jialing Lv; Guilin Pan
Journal:  Medicine (Baltimore)       Date:  2021-11-05       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.